Blueprint Medicines Corp share price logo

Blueprint Medicines Corp Share Price

NASDAQ: BPMC

$129.49

+0.21

(+0.16%)

as on

Bell Icon

The stock has been delisted from the stock exchange on 17 Jul 2025

Blueprint Medicines Corp Stock Performance

as on July 18, 2025 at 1:29 am IST

  • $129.49
    $129.49
  • 52 Week's Low

    52 Week's High

    $73.04
    $129.65
    downward going graph

    43.59%

    Downside

    0.12%

    Upside

    downward going graph

Blueprint Medicines Corp share price movements today

Previous Close
$129.28
Open
$129.49
Volume
422.0
Day's Low - High
$129.49 - $129.49
52 Week Low - High
$73.04 - $129.65

Blueprint Medicines Corp Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Blueprint Medicines Corp Stock Fundamentals & Key Indicators

Check Blueprint Medicines Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

Return On Equity TTM

0.00%

Blueprint Medicines Corp stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Blueprint Medicines Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$-NANA0.00%

Analyst Recommendation on Blueprint Medicines Corp Stock

Based on 23 analysts

BUY

73.91%

Buy

17.39%

Hold

8.70%

Sell

Based on 23 analysts, 73.91% of analysts recommend a 'BUY' rating for Blueprint Medicines Corp. Average target price of $130.6

Blueprint Medicines Corp Share Price Target

Get share price movements and forecasts by analysts on Blueprint Medicines Corp.

What analysts predicted

0.85%UPSIDE

Target Price

$130.6

Current Price

$129.49

Analyzed by

23 Analysts

Target

$130.60

Blueprint Medicines Corp target price $130.6, a slight upside of 0.85% compared to current price of $129.49. According to 23 analysts rating.

Blueprint Medicines Corp Quarterly Profit & Loss

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Total Revenue
38
63
57
56
71
96
138
128
146
149
Gross Profit
33
60
55
52
70
88
126
126
138
146
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-158
-129
-132
-133
-110
89
-49
-56
-49
0
Net Profit Margin
-409.06%
-204.72%
-230.66%
-236.38%
-154.14%
92.74%
-36.19%
-43.90%
-34.13%
0.33%

Blueprint Medicines Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
11
27
21
44
66
793
180
204
249
508
Gross Profit
-37
-53
-123
-199
66
793
162
186
236
488
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-52
-72
-148
-236
-328
313
-644
-557
-506
-67
Net Profit Margin
-462.89%
-261.04%
-691.30%
-531.53%
-494.20%
39.54%
-357.67%
-273.24%
-203.30%
-13.19%

Global Institutional Holdings in Blueprint Medicines Corp

Funds
Holdings
BlackRock Inc
10.38%
Vanguard Group Inc
10.27%
T. Rowe Price Associates, Inc.
8.38%
venBio Select Advisor LLC
5.95%
Wellington Management Company LLP
4.75%

About Blueprint Medicines Corp

Blueprint Medicines Corporation is a fully integrated, commercial-stage, global biopharmaceutical company. The Company invents life-changing medicines in two core, strategic areas of allergy/inflammation and oncology/hematology. The Company delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritinib) and PDGFRA Exon 18 mutant GIST in the United States and Europe. It has a pipeline of research and development programs that range from early science to advanced clinical trials in mast cell-mediated diseases, including systemic mastocytosis (SM) and chronic urticaria, breast cancer, and other solid tumors vulnerable to CDK2 inhibition. Its pipeline includes Elenestinib (BLU-263), BLU-808, and BLU-956. It is developing Elenestinib (BLU-263), an investigational, orally available, potent and highly selective KIT inhibitor, for the treatment of indolent SM and other mast cell disorders. It is advancing BLU-808, a potent and selective wild-type KIT inhibitor, for mast cell diseases.
OrganisationBlueprint Medicines Corp
E-voting on sharesClick here to vote

FAQs

What is Blueprint Medicines Corp share price today?

Blueprint Medicines Corp share price today is $129.49 as on at the close of the market. Blueprint Medicines Corp share today touched a day high of $129.49 and a low of $129.49.

What is the 52 week high and 52 week low for Blueprint Medicines Corp share?

Blueprint Medicines Corp share touched a 52 week high of $129.65 on and a 52 week low of $73.04 on . Blueprint Medicines Corp stock price today i.e. is closed at $129.49,which is 0.12% down from its 52 week high and 77.29% up from its 52 week low.

How to invest in Blueprint Medicines Corp Stock (BPMC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Blueprint Medicines Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Blueprint Medicines Corp Shares that will get you 0.0116 shares as per Blueprint Medicines Corp share price of $129.49 per share as on July 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Blueprint Medicines Corp Stock (BPMC) from India?

Indian investors can start investing in Blueprint Medicines Corp (BPMC) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Blueprint Medicines Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Blueprint Medicines Corp share’s latest price of $129.49 as on July 18, 2025 at 1:29 am IST, you will get 0.0772 shares of Blueprint Medicines Corp. Learn more about fractional shares .